ScanBalt BioRegion to collaborate on cancer

NewsGuard 100/100 Score

Up to forty three (43) percent of all cancer cases can be prevented by prevention programmes according to The World Health Organization (WHO).

Thereby coordinated cross-border efforts have a significant potential for improving the health of the populations in the Baltic Sea Region.

Hans-Robert Metelmann, Professor at Greifswald University, Chairman of ScanBalt, says “Prevention is a pillar of health care. Effective cancer prevention is a task between life sciences, humanities, social sciences, politics and public-private collaboration on drug development. In ScanBalt BioRegion, the established platform for cross-border collaboration, we have a unique tool to effectively improve health. We will now explore the possibilities to establish concrete projects and involve key stakeholders from research, politics, and education, industry and opinion makers. It is the aim to make cancer prevention an integral component of the social and personal behaviour around the Baltic Sea Region”.

Collaboration on cancer in ScanBalt BioRegion is also expected to be an important theme for ScanBalt Academy. ScanBalt Academy is a group of distinguished and prominent life scientists from academia as well as industry and government. The vision is to promote research quality in ScanBalt BioRegion, to Identify and promote fields of research where collaborative trans-national public-private efforts in ScanBalt BioRegion can become global leaders and to be ambassadors with the purpose of attracting human, financial and industrial resources.

The inauguration assembly of the Academy will take place in Schwerin/Germany, ScanBalt House, 12th of March 2008. The assembly will be hosted by the Minister President of Mecklenburg-Vorpommern, Dr. Harald Ringstorff.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels